Tina Larson
President at RECURSION PHARMACEUTICALS, INC.
Net worth: 5 M $ as of 30/04/2024
Tina Larson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Chief Operating Officer | 01/07/2018 | - |
| President | 01/10/2019 | - | |
Revagenix , Inc.
 Revagenix , Inc. BiotechnologyHealth Technology Revagenix, Inc. engages in the research and development of antibiotics. The company is based in San Mateo, CA. The company was founded in 2019 by Ryan Cirz and Andrew McCandlish. Ryan Cirz has been the CEO since 2019. | Chairman | - | - |
Career history of Tina Larson
Former positions of Tina Larson
| Companies | Position | Start | End |
|---|---|---|---|
| ACHAOGEN | Corporate Officer/Principal | 01/05/2016 | 01/06/2018 |
| Roche, Inc. | Corporate Officer/Principal | 01/10/2014 | 01/04/2016 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Training of Tina Larson
| Colorado State University | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 1 |
| President | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| RECURSION PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Roche, Inc. | |
Revagenix , Inc.
Revagenix , Inc. BiotechnologyHealth Technology Revagenix, Inc. engages in the research and development of antibiotics. The company is based in San Mateo, CA. The company was founded in 2019 by Ryan Cirz and Andrew McCandlish. Ryan Cirz has been the CEO since 2019. | Health Technology |
- Stock Market
- Insiders
- Tina Larson
- Experience
